Novavax, Inc.
NVAX
$9.06
-$0.29-3.10%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -87.84M | 440.30M | 341.75M | 422.82M | 478.70M |
| Total Depreciation and Amortization | 22.34M | 27.61M | 35.01M | 41.12M | 44.69M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 147.06M | 175.16M | 107.58M | -13.94M | 12.79M |
| Change in Net Operating Assets | -173.12M | -887.71M | -862.65M | -1.08B | -725.38M |
| Cash from Operations | -91.56M | -244.64M | -378.32M | -630.94M | -189.21M |
| Capital Expenditure | -5.61M | -5.94M | -5.79M | -5.15M | -7.77M |
| Sale of Property, Plant, and Equipment | -- | -- | 192.64M | 192.64M | 192.64M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -27.70M | -72.33M | -141.60M | 26.20M | -454.98M |
| Cash from Investing | -33.31M | -78.27M | 45.26M | 213.70M | -270.11M |
| Total Debt Issued | 89.02M | 42.61M | 42.61M | -- | -- |
| Total Debt Repaid | -8.45M | -10.07M | -6.55M | -6.08M | -5.84M |
| Issuance of Common Stock | 5.29M | 5.29M | 5.29M | 415.00K | 258.38M |
| Repurchase of Common Stock | -5.29M | -5.29M | -5.95M | -5.95M | -666.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8.10M | -4.80M | -4.47M | 0.00 | -4.24M |
| Cash from Financing | 72.47M | 27.74M | 30.92M | -11.62M | 247.64M |
| Foreign Exchange rate Adjustments | 6.84M | 5.93M | -3.08M | 2.29M | -5.78M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -45.56M | -289.24M | -305.23M | -426.58M | -217.46M |